Furthermore, results demonstrate that Glycogen synthase kinase 3‐beta (GSK3‐β), a key enzyme implicated in AD due to its role in tau protein hyperphosphorylation, can be effectively targeted by polyphenolic compounds. The gene discussed is MAPT; the disease is Alzheimer disease.